Papers
1
Total Citations
15
H-Index
1
About
Dr. Richa Rai is a distinguished cancer researcher whose work bridges urologic oncology and tumor immunology, with a particular focus on prostate cancer (PCa) biology. Her landmark 2022 study, "Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer," was the first to investigate how pelvic inflammation influences PCa aggressiveness and clinical outcomes following radical prostatectomy. This pioneering work, which has garnered 15 citations, has opened a critical new avenue in understanding the tumor microenvironment's role in cancer progression. Dr. Rai's research is notable for its translational impact, directly linking inflammatory biomarkers to aggressive disease phenotypes and offering potential new targets for risk stratification and therapy. By identifying pelvic inflammation as a previously overlooked factor in PCa biology, she has provided clinicians with a novel framework for predicting patient outcomes. Her contributions are shaping how the field views the interplay between chronic inflammation and cancer aggressiveness, making her a rising voice in precision oncology.
Research Focus
Key Achievements
Top Papers
- 1